MetLife has reached an arrangement to invest in the managed vision-care business Versant Health from a group of traders led by Centerbridge Partners and which include FFL Partners for $1.675 billion in an all-hard cash transaction.
Versant owns the market manufacturers Davis Eyesight and Outstanding Eyesight, which has about 35 million users. MetLife stated following the offer it would develop into the 3rd-greatest vision insurance provider by membership in the U.S. The business has made available group vision considering the fact that 2012 and it has a fifteen% marketplace share in U.S. group positive aspects. It stated immediately after the acquisition it will have about 38 million vision-care users.
It is financing the offer with hard cash on hand.
“We are self-assured this acquisition will make our marketplace-foremost group positive aspects business enterprise even a lot more interesting,” Ramy Tadros, president of U.S. business enterprise for MetLife, stated. “The addition